S&P 500
(0.85%) 5 421.03 points
Dow Jones
(-0.09%) 38 712 points
Nasdaq
(1.53%) 17 608 points
Oil
(0.63%) $78.39
Gas
(-2.94%) $3.04
Gold
(0.46%) $2 337.40
Silver
(1.64%) $29.71
Platinum
(0.52%) $963.90
USD/EUR
(-0.61%) $0.925
USD/NOK
(-1.11%) $10.58
USD/GBP
(-0.47%) $0.781
USD/RUB
(-0.28%) $89.00

FY/2023

Generated By Getagraph.com: 2023-12-31

Warby Parker Inc. [WRBY] -0.54% $ 16.56
Exchange: NYSE Sector: Healthcare Industry: Medical - Instruments & Supplies

Warby Parker Fourth Quarter and Full Year 2023 Results

Operator: Ladies and gentlemen, welcome to the Warby Parker Fourth Quarter and Full Year 2023 Results. My name is Neil and I will be coordinating your call today. [Operator Instructions] I will now hand over to Jaclyn Berkley, Head of the Investor Relations, to begin. Jaclyn, please go ahead.

Jaclyn Berkley: Thank you and good morning, everyone. Here with me today are Neil Blumenthal and Dave Gilboa, our Co-Founders and Co-CEOs, alongside Steve Miller, Senior Vice President and Chief Financial Officer. Before we begin, we have a couple of reminders. Our earnings release and slide presentation are available on our website at investor.warbyparker.com. During this call and in our presentation, we will be making comments of a forward-looking nature. Actual results may differ materially from those expressed or implied as a result of various risks and uncertainties. For more information about some of these risks, please review the company's SEC filings, including the section titled Risk Factors in the company's latest annual report on Form 10-K. These forward-looking statements are based on information as of February 28, 2024 and except as required by law, we assume no obligation to publicly update or revise our forward-looking statements. Additionally, we will be discussing certain non-GAAP financial measures. These non-GAAP financial measures are in addition to and not a substitute for measures of financial performance prepared in accordance with U.S. GAAP. A reconciliation of our non-GAAP measures to the most directly comparable U.S. GAAP measures can be found in this morning's press release and our slide deck available on our IR website. And with that, I'll pass it over to Dave to kick us off.

Dave Gilboa: Welcome, everyone, and thank you for joining us this morning. We'll spend the majority of today's call speaking to our 2024 plan and looking forward. But first, I want to take a moment to reflect on 2023. It's a year that we have a lot to be proud of, and I'd like to start by recognizing our team's hard work and dedication to delivering the best eyecare products and experiences for our customers while improving our financial results and making progress against our mission to provide vision for all. Last year we delivered consistent double-digit revenue growth each quarter closing the year up 12% year-over-year while growing adjusted EBITDA more than 90% and expanding adjusted EBITDA margin nearly 330 basis points. We are pleased to have achieved a full year of positive free cash flow while we continue to make significant investments in our long-term strategic initiatives; including opening 40 new stores, scaling contacts and eye exams to approximately 9% and 4% of revenue respectively and introducing new innovative products like precision progressives. We are also proud to have surpassed a major milestone of distributing more than 15 million pairs of glasses to people in need through our Buy a Pair, Give a Pair program. But what we hope you'll take away from today's call is that we're not content. We have higher ambitions, in particular for top-line growth and preserving more customers, all while maintaining operational discipline and expanding profitability. A focus for 2024 and beyond will be to improve our top-line growth rate, and we are pleased with the positive momentum we have seen so far year-to-date. Turning to our plan. You'll hear a lot of consistency in our priorities from last year, but we also want to make it clear where we are leaning into opportunities or making adjustments in response to recent learnings. There are 3 key areas in 2024 that we expect will be meaningfully different from the last 2 years. One, we plan to increase our marketing and brand spend on a full-year basis for the first time since 2021. Two, we expect to drive positive sustained e-com growth also for the first time since 2021. And three, we will take a leap forward in our ability to serve insurance customers. Alongside these 3 areas, we plan to continue driving best-in-class retail economics and outsized growth in product categories like progressives, contacts, and exams. We believe these actions will reaccelerate active customer growth and overall glasses growth in 2024 and beyond.

Financial Overview

Revenues FY - 2023

Revenue Gross Profit Operating Expenses Interest Expense EBITDA Net Income EPS
$669.77M $352.81M $424.80M $0 $-33.44M $-63.20M $-0.540

Balance FY - 2023

Net IncomeDepreciation and AmortizationStock Based CompensationChange in Working CapitalNet Cash Provided by Operating ActivitiesCapital ExpenditureFree Cash Flow
$-63.20M$38.55M$70.51M$5.81M$60.99M$-53.67M$7.32M

Other Reports

Symbol Period Year Title
PETS Q4 2024 PetMed Express Inc. Q4 FY2024 Financial Results
MPAA Q4 2024 Motorcar Parts of America Inc. Fiscal Year 2024 Financial Report
CAL Q1 2024 Caleres Inc. First Quarter 2024 Financial Results
FCELB Q2 2024 FuelCell Energy, Inc. (FCELB) Q2 2024 Financial Results
FCEL Q2 2024 FuelCell Energy Inc: Q2 FY2024 Financial Results
CVGW Q2 2024 Calavo Growers Inc - Q2 2024 Financial Results
SKIL Q1 2025 Q1 2025 Financial Results for Skillsoft Corp.
SCVL Q1 2024 Shoe Carnival, Inc. Q1 2023 Fiscal Report
AZO Q3 2024 AutoZone Inc. 2024 Q3 Financial Results
GHM FY 2023 Graham Corporation's Fourth Quarter Fiscal Year 2024 Financial Results
GHM Q4 2023 Graham Corporation's Fourth Quarter 2023 Financial Results
AGX Q1 2025 Argan, Inc. Q1 FY2025 Financial Results
LAKE Q1 2025 Lakeland Industries Inc. Announces Fiscal 2025 First Quarter Financial Results
COST Q3 2024 Costco Wholesale Corporation Q3 2024 Financial Report
CPB Q3 2024 Campbell Soup Co Q3 Fiscal 2024 Financial Report
SRRE FY 2023 Sunrise Real Estate Group, Inc. Financial Results - FY 2023
SMTC Q1 2025 Financial Results for Semtech Corp (SMTC) - Q1 2025
SMAR Q1 2025 Financial Results for Smartsheet Inc - Q1 2025
CXM Q1 2025 Sprinklr, Inc. Q1 2025 Financial Report
CHPT Q1 2025 Switchback Energy Acquisition Corporation (CHPT) Q1 2024 Financial Results
BBWI Q1 2024 Bath & Body Works Q1 2024 Financial Report
VRNT Q1 2025 Financial Results Q1 FY25 for Verint Systems Inc. (NASDAQ: VRNT)
CRWD Q1 2025 CrowdStrike Holdings Inc. Q1 Fiscal Year 2025 Financial Results
VEEV Q1 2025 Veeva Systems Inc. Fiscal 2025 Q1 Financial Results
VEEV Q1 2025 Veeva Systems Inc Reports Fiscal 2025 First Quarter Results
HQY Q1 2025 HealthEquity Inc. Q1 Fiscal Year 2025 Earnings Report
GTLB Q1 2025 GitLab Inc. Financial Results for the First Quarter of Fiscal Year 2025
BURL Q1 2024 Burlington Stores Inc. Q1 2024 Financial Report
LGF-B Q4 2024 Lions Gate Entertainment Corp. FY 2024 Financial Results
RSVRW FY 2023 Reservoir Media, Inc. Financial Results for Q4 2023
RSVR FY 2023 Reservoir Media Q3 FY2024 Financial Report
AI Q4 2024 C3.ai, Inc. Q4 2024 Financial Results
OOMA Q1 2025 Ooma Inc Q1 2025 Financial Results
MAPSW Q4 2023 Q1 2024 Financial Results for WM Technology, Inc.
MAPS Q4 2023 WM Technology, Inc. (MAPS) Q1 2024 Financial Results
STEP Q4 2024 StepStone Group Inc. (NASDAQ: STEP) Fiscal Q4 2024 Financial Results
SNPS Q2 2024 Synopsys Inc. Q2 Fiscal Year 2024 Financial Report
BYFC Q1 2024 Q1 2024 Financial Results for Broadway Financial Corp (BYFC)
LGF-A Q4 2024 FY 2024 Financial Results - Lions Gate Entertainment Corp (LGF-A)
MOD Q4 2024 Modine Manufacturing Co. Fourth Quarter and Fiscal Year 2024 Financial Report
LPG Q4 2023 Dorian LPG Ltd. Q4 2023 Financial Report
EA Q4 2024 Electronic Arts Inc. Reports Fourth Quarter and Fiscal Year End 2024 Financial Results
TTWO FY 2024 Take-Two Interactive Software Inc. Q4 and Fiscal Year 2024 Financial Results
AGYS Q4 2023 Agilysys Inc Fiscal Year 2023 Fourth Quarter and Full Year Financial Results
TARO Q4 2024 Taro Pharmaceutical Industries Ltd - FY2024 Financial Results
HAE Q4 2024 Haemonetics Corporation Q4 2024 Financial Results
MESA Q1 2024 Q1 2024 Financial Results: Mesa Air Group Inc (NASDAQ: MESA)
HAE FY 2024 Haemonetics Corporation Q4 2024 Financial Report
ROLLP FY 2023 ROLLP Financial Results for Fiscal Year 2023
ROLL FY 2023 RBC Bearings Q1 Fiscal Year 2023 Financial Report